바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.83 No.3
Citation Share

Validation of the Korean Version of the Bronchiectasis Health Questionnaire

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2020, v.83 no.3, pp.228-233
https://doi.org/10.4046/trd.2020.0025

Hyun Lee (Hanyang University)
Sang-Heon Kim (Hanyang University)





Hyun, L. , Sang-Heon, K. , & (2020). Validation of the Korean Version of the Bronchiectasis Health Questionnaire. Tuberculosis & Respiratory Diseases, 83(3), 228-233, https://doi.org/10.4046/trd.2020.0025
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: The Bronchiectasis Health Questionnaire (BHQ) is a simple and repeatable, self-reporting health status questionnaire for bronchiectasis. We have translated the original version of the BHQ into Korean using a standardized methodology. The purpose of this study was to assess the validity of the Korean version of the BHQ (K-BHQ) with Korean patients. Methods: Stable state patients with bronchiectasis from two academic hospitals were enrolled in this study. The validity was assessed by investigating the relationship between the K-BHQ scores and the Korean version of the Chronic Obstructive Pulmonary Disease Assessment Test (K-CAT) scores. We also investigated the relationship between the K-BHQ scores and other variables of the modified Medical Research Council’s (mMRC) dyspnea scale, lung function, and exacerbations. Results: A total of 126 patients with bronchiectasis were enrolled. The mean age was 64.3 (standard deviation [SD], 9.7). Women comprised 53.2% of the patients. The mean forced expiratory volume in one second (FEV1) was 60% of the predicted value (SD, 18.9%); the mean K-CAT score was 17.6 (SD, 9.1). The K-BHQ scores correlated strongly with the K-CAT scores (r=–0.656, p<0.001). There was significant correlation between the K-BHQ scores and the mMRC dyspnea scale (ρ=–0.409, p<0.001), FEV1 (r=0.406, p<0.001), and number of exacerbations requiring hospitalization (ρ=–0.303, p=0.001). Conclusion: The K-BHQ is valid for assessing the health-related quality of life or health status of Korean bronchiectasis patients.

keywords
Bronchiectasis, Bronchiectasis Health Questionnaire, Validation

Reference

1.

1. Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017;50:1700629.

2.

2. Quint JK, Millett ER, Joshi M, Navaratnam V, Thomas SL, Hurst JR, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J 2016;47:186-93.

3.

3. Goeminne PC, Hernandez F, Diel R, Filonenko A, Hughes R, Juelich F, et al. The economic burden of bronchiectasis -known and unknown: a systematic review. BMC Pulm Med 2019;19:54.

4.

4. Choi H, Yang B, Nam H, Kyoung DS, Sim YS, Park HY, et al. Population-based prevalence of bronchiectasis and associated comorbidities in South Korea. Eur Respir J 2019;54:1900194.

5.

5. Quittner AL, O’Donnell AE, Salathe MA, Lewis SA, Li X, Montgomery AB, et al. Quality of Life Questionnaire-Bronchiectasis:final psychometric analyses and determination of minimal important difference scores. Thorax 2015;70:12-20.

6.

6. Spinou A, Fragkos KC, Lee KK, Elston C, Siegert RJ, Loebinger MR, et al. The validity of health-related quality of life questionnaires in bronchiectasis: a systematic review and metaanalysis. Thorax 2016;71:683-94.

7.

7. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A selfcomplete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.

8.

8. Xu Z, Lin R, Che G, Wang M, Ji Y, Li P, et al. Validation of the Mandarin Chinese version of the Leicester Cough Questionnaire in patients undergoing lung resection for patients with lung disease. Zhongguo Fei Ai Za Zhi 2017;20:389-94.

9.

9. Spinou A, Siegert RJ, Guan WJ, Patel AS, Gosker HR, Lee KK, et al. The development and validation of the Bronchiectasis Health Questionnaire. Eur Respir J 2017;49:1601532.

10.

10. Lee H, Choi H, Sim YS, Park S, Kim WJ, Yoo KH, et al. KMBARC registry: protocol for a multicentre observational cohort study on non-cystic fibrosis bronchiectasis in Korea. BMJ Open 2020;10:e034090.

11.

11. Lee BY, Lee S, Lee JS, Song JW, Lee SD, Jang SH, et al. Validity and reliability of CAT and Dyspnea-12 in bronchiectasis and tuberculous destroyed lung. Tuberc Respir Dis 2012;72:467-74.

12.

12. Quittner AL, Marciel KK, Salathe MA, O’Donnell AE, Gotfried MH, Ilowite JS, et al. A preliminary quality of life questionnaire-bronchiectasis: a patient-reported outcome measure for bronchiectasis. Chest 2014;146:437-48.

13.

13. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 2005;8:94-104.

14.

14. De la Rosa Carrillo D, Olveira C, Garcia-Clemente M, Giron-Moreno RM, Nieto-Royo R, Navarro-Rolon A, et al. COPD assessment test in bronchiectasis: minimum clinically important difference and psychometric validation: a prospective study. Chest 2020;157:824-33.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy